All Access Articles |
- Intellia Therapeutics Increases Market Sale Agreement by Over $1 Billion | 2026-03-02 | UNITED STATES
- FDA lifts clinical hold on Intellia Therapeutics' Nexiguran Ziclumeran trial | 2026-01-27 | UNITED STATES
- Intellia Therapeutics Reports Positive Three-Year Data for Lonvo-Z | 2025-06-16 | BIOTECHNOLOGY
- Intellia Therapeutics Reports Q4 2024 Financial Results | 2025-02-27 | BIOTECHNOLOGY